Advanced Solid Tumors With Neuroendocrine Differentiation
1 clinical trials · Condition
◉ Watch Advanced Solid Tumors With Neuroendocrine Differentiation
| Record | Firm | Date |
|---|---|---|
| A Study of Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy (NCT06156332) | Shanghai Changzheng Hospital | 2024-01-28 |
Track Advanced Solid Tumors With Neuroendocrine Differentiation automatically
Every clearance here is in the API, with alerts when new ones post.